Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Journal of autoimmunity

Showing results (11-20 of 3,690) with videos related to

Pageof 369
Sort By:
Journal of Autoimmunity|September 2, 2000
Which are the best biological markers of the antiphospholipid syndrome?L O Carreras, R R Forastiero, M E Martinuzzo
Journal of Autoimmunity|September 2, 2000
Use of the dilute Russell viper venom time (dRVVT): its importance and pitfallsD A Triplett
Journal of Autoimmunity|September 2, 2000
Overview on anticardiolipin ELISA standardizationA Tincani, G Balestrieri, F Allegri, et al.
Journal of Autoimmunity|September 2, 2000
Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosisY Shoenfeld, D Harats, J George
Journal of Autoimmunity|September 2, 2000
Hormonal contraception and replacement and the use of androgens in the antiphospholipid syndromeR G Lahita
Journal of Autoimmunity|September 2, 2000
New developments in viral peptides and APL inductionA E Gharavi, S S Pierangeli, E N Harris
Journal of Autoimmunity|September 2, 2000
Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?R H Derksen, P G de Groot
Journal of Autoimmunity|September 2, 2000
Antiphospholipid syndrome and heparin-induced thrombocytopenia: update on similarities and differencesY Gruel
Journal of Autoimmunity|September 2, 2000
Speculations on APS in the coming millenniumG Hughes
Journal of Autoimmunity|April 11, 2000
B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expressionC A White, K B Nguyen, M P Pender
Pageof 369

Showing results (11-20 of 3,690) with videos related to

Sort By:
Pageof 369
Journal of Autoimmunity|September 2, 2000
Which are the best biological markers of the antiphospholipid syndrome?L O Carreras, R R Forastiero, M E Martinuzzo
Journal of Autoimmunity|September 2, 2000
Use of the dilute Russell viper venom time (dRVVT): its importance and pitfallsD A Triplett
Journal of Autoimmunity|September 2, 2000
Overview on anticardiolipin ELISA standardizationA Tincani, G Balestrieri, F Allegri, et al.
Journal of Autoimmunity|September 2, 2000
Heat shock protein 60/65, beta 2-glycoprotein I and oxidized LDL as players in murine atherosclerosisY Shoenfeld, D Harats, J George
Journal of Autoimmunity|September 2, 2000
Hormonal contraception and replacement and the use of androgens in the antiphospholipid syndromeR G Lahita
Journal of Autoimmunity|September 2, 2000
New developments in viral peptides and APL inductionA E Gharavi, S S Pierangeli, E N Harris
Journal of Autoimmunity|September 2, 2000
Do we know which patients with the antiphospholipid syndrome should receive long-term high dose anti-coagulation?R H Derksen, P G de Groot
Journal of Autoimmunity|September 2, 2000
Antiphospholipid syndrome and heparin-induced thrombocytopenia: update on similarities and differencesY Gruel
Journal of Autoimmunity|September 2, 2000
Speculations on APS in the coming millenniumG Hughes
Journal of Autoimmunity|April 11, 2000
B cell apoptosis in the central nervous system in experimental autoimmune encephalomyelitis: roles of B cell CD95, CD95L and Bcl-2 expressionC A White, K B Nguyen, M P Pender
Pageof 369